IOLCP vs LUPIN: Stock Comparison

IOL Chemicals and Pharmaceuticals Limited vs Lupin Limited

Live data: 22 July 2026, 3:03 PM IST • Source: NSE and company filings

Lupin Limited is the larger company by market capitalisation. IOL Chemicals and Pharmaceuticals Limited shows a higher dividend yield and lower leverage, while Lupin Limited shows a lower P/E, a higher ROE and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of IOL Chemicals and Pharmaceuticals Limited and Lupin Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, IOLCP is more favourable on 3 of 13 scored metrics and LUPIN on 10These counts are context-free and are not an overall rating.

Key Differences

Market Cap
LUPIN is the larger company
₹1.1 L Cr vs ₹4,363 Cr
P/E Ratio
LUPIN has a lower P/E
21.56x vs 32.2x
P/B Ratio
IOLCP has a lower P/B
2.46x vs 5.12x
EPS
LUPIN has higher earnings per share
₹116.56 vs ₹4.69
Dividend Yield
IOLCP has a higher dividend yield
0.64% vs 0.48%
Revenue Growth (TTM YoY)
LUPIN has faster revenue growth
31.9% vs 17.4%
EPS Growth (TTM YoY)
LUPIN has faster EPS growth
89% vs 69.7%
Qtr Sales Growth
LUPIN has stronger quarterly sales growth
31.9% vs 17.4%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricIOLCPLUPIN
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricIOLCPLUPIN
Live Price₹148.4₹2,408.6
Day Change-1.72%-4.22%
Volume13.07 L10.4 L
52-Week High₹179.6₹2,529.5
52-Week Low₹67.19₹1,836.8
Distance from 52W High-17.37%-4.78%

Valuation

MetricIOLCPLUPIN
Market Cap₹4,363 Cr₹1.1 L Cr
P/E Ratio32.2x21.56x
P/B Ratio2.46x5.12x
EPS₹4.69₹116.56
Book Value₹61.24₹491.29
Dividend Yield0.64%0.48%

Growth

MetricIOLCPLUPIN
Revenue Growth (TTM YoY)17.4%31.9%
EPS Growth (TTM YoY)69.7%89%
Qtr Sales Growth17.4%31.9%
Qtr Profit Growth69.2%101%

Profitability & Leverage

MetricIOLCPLUPIN
ROE8.38%29.1%
ROCE11.2%30.3%
Net Margin5.94%17.65%
Operating Margin11.6%31.5%
Debt to Equity0.08x0.29x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricIOLCPLUPIN
Promoter Holding62.28% 4.8 pp46.57% 0.04 pp
FII Holding4.87% 3.15 pp21.71% 0.22 pp
DII Holding0.43% 0.41 pp25.32% 0.26 pp
Public Holding32.42% 8.36 pp6.11% 0.08 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: IOL Chemicals and Pharmaceuticals Limited and Lupin Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.